pyrazines has been researched along with Memory Disorders in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Iwashita, H; Nakashima, M; Shiraishi, E; Suzuki, N | 1 |
| Jiang, SJ; Liu, J; Qin, XH; Wang, J; Wang, LX; Zhang, Q; Zhu, L | 1 |
| Li, W; Li, X; Liang, X; Lu, F; Wei, K; Yao, Y; Zhang, J; Zhang, Q | 1 |
| Apaijai, N; Chattipakorn, N; Chattipakorn, SC; Pintana, H | 1 |
| Luo, XP; Wu, W; Yang, SH; Yu, X; Zheng, D | 1 |
| Guo, XL; Liu, XY; Shi, XM; Sun, R; Wang, WF; Yu, LG; Zhang, H | 1 |
| Abbatecola, AM; D'Amico, M; Di Filippo, C; Ferraraccio, F; Marfella, R; Paolisso, G; Rossi, F | 1 |
| Briggs, MA; Bruton, G; Calver, AR; Chessell, I; Crook, B; Davis, JB; Davis, RP; Foley, AG; Heslop, T; Hirst, WD; Medhurst, AD; Medhurst, SJ; Ociepka, S; Orlek, B; Ray, A; Regan, CM; Sargent, B; Schogger, J; Stean, TO; Trail, BK; Upton, N; White, T; Wilson, DM | 1 |
| Conrad, CA; Gelke, CK; Grove, W; Kudelka, AP; Meyers, CA; Pazdur, R | 1 |
1 trial(s) available for pyrazines and Memory Disorders
| Article | Year |
|---|---|
Neurotoxicity of CI-980, a novel mitotic inhibitor.
Topics: Adult; Aged; Antineoplastic Agents; Carbamates; Cognition; Cognition Disorders; Colorectal Neoplasms; Female; Humans; Male; Memory; Memory Disorders; Middle Aged; Neuropsychological Tests; Neurotoxins; Ovarian Neoplasms; Pyrazines; Pyridines | 1997 |
8 other study(ies) available for pyrazines and Memory Disorders
| Article | Year |
|---|---|
TAK-915, a phosphodiesterase 2A inhibitor, ameliorates the cognitive impairment associated with aging in rodent models.
Topics: Aging; Animals; Brain; Cognition; Cognition Disorders; Cognitive Dysfunction; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 2; Male; Memory Disorders; Memory, Episodic; Phosphodiesterase Inhibitors; Pyrazines; Pyridines; Rats; Rats, Inbred F344; Rats, Long-Evans; Rats, Sprague-Dawley | 2019 |
Ligustrazine Attenuates Hyperhomocysteinemia-induced Alzheimer-like Pathologies in Rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Disease Models, Animal; Hippocampus; Humans; Hyperhomocysteinemia; Memory Disorders; Neurons; Neuroprotective Agents; Phosphorylation; Pyrazines; Rats; Rats, Sprague-Dawley | 2021 |
Tetramethylpyrazine reverses intracerebroventricular streptozotocin-induced memory deficits by inhibiting GSK-3β.
Topics: Alzheimer Disease; Animals; Glycogen Synthase Kinase 3; Hippocampus; Injections, Intraventricular; Learning; Male; Memory; Memory Disorders; Neurons; Neuroprotective Agents; Pyrazines; Rats, Wistar; Streptozocin | 2017 |
DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats.
Topics: Adamantane; Animals; Behavior, Animal; Brain; Cognition Disorders; Diabetes Mellitus, Type 2; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Hippocampus; Insulin Resistance; Male; Maze Learning; Memory; Memory Disorders; Mitochondria; Nitriles; Obesity; Oxidative Stress; Pyrazines; Pyrrolidines; Rats; Rats, Wistar; Sitagliptin Phosphate; Triazoles; Vildagliptin | 2013 |
Tetramethylpyrazine protects against scopolamine-induced memory impairments in rats by reversing the cAMP/PKA/CREB pathway.
Topics: Animals; Brain Chemistry; Carrier Proteins; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Electrophoresis, Polyacrylamide Gel; Homer Scaffolding Proteins; Male; Maze Learning; Memory Disorders; Muscarinic Antagonists; Neuroprotective Agents; Polymerase Chain Reaction; Pyrazines; Rats; Rats, Wistar; RNA; Scopolamine; Signal Transduction; Transcription, Genetic | 2013 |
A tetramethylpyrazine piperazine derivate CXC137 prevents cell injury in SH-SY5Y cells and improves memory dysfunction of rats with vascular Dementia.
Topics: Adenosine Triphosphate; Animals; Calcium; Cell Line, Tumor; Dementia, Vascular; Humans; Male; Memory Disorders; Piperazines; Pyrazines; Rats; Rats, Sprague-Dawley | 2014 |
Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Memory Disorders; Mice; Mice, Transgenic; Motor Activity; Pyrazines; Sitagliptin Phosphate; Triazoles | 2010 |
Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats.
Topics: Analgesics; Animals; Avoidance Learning; Azepines; Benzazepines; Capsaicin; Central Nervous System; Drinking; Histamine Agonists; Histamine Antagonists; Humans; Male; Memory Disorders; Neuralgia; Pyrazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Histamine H3; Scopolamine | 2007 |